4//SEC Filing
Lee's Pharmaceutical Holdings Ltd 4
Accession 0001213900-19-025800
CIK 0000946486other
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 7:54 PM ET
Size
8.2 KB
Accession
0001213900-19-025800
Insider Transaction Report
Form 4
Lee's Pharmaceutical Holdings Ltd
10% Owner
Transactions
- Purchase
Common Stock
2019-12-06$3.02/sh+1,655,629$5,000,000→ 14,450,599 total(indirect: By Subsidiary) - Purchase
Series I Warrants
2019-12-06+827,815→ 827,815 total(indirect: By Subsidiary)Exercise: $4.03From: 2020-06-06Exp: 2024-12-05→ Common Stock (827,815 underlying)
Footnotes (1)
- [F1]Effective December 6, 2019 the Issuer entered into a Securities Purchase Agreement (the "SPA") with certain investors whereby LPH II Investments Limited ("LPH II"), a wholly owned subsidiary of the Reporting Person, subscribed for and purchased 1,655,629 shares of Common Stock of the Issuer. Pursuant to the SPA, the Issuer issued and LPH II received: (i) 1,655,629 shares of Common Stock; and (ii) 827,815 Series I Warrants to purchase 827,815 shares of Common Stock at an exercise price of $4.03 per share.
Documents
Issuer
WINDTREE THERAPEUTICS INC /DE/
CIK 0000946486
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001722778
Filing Metadata
- Form type
- 4
- Filed
- Dec 9, 7:00 PM ET
- Accepted
- Dec 10, 7:54 PM ET
- Size
- 8.2 KB